Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1259

1.

Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.

Bai YM, Su TP, Tsai SJ, Wen-Fei C, Li CT, Pei-Chi T, Mu-Hong C.

J Affect Disord. 2014 Sep;166:187-92. doi: 10.1016/j.jad.2014.05.009. Epub 2014 May 21.

PMID:
25012430
[PubMed - in process]
2.

Lifetime mood spectrum symptoms among bipolar patients and healthy controls: A cross sectional study with the Mood Spectrum Self-Report questionnaire.

Ghouse AA, Sanches M, Zunta-Soares GB, Soares JC.

J Affect Disord. 2014 Sep;166:165-7. doi: 10.1016/j.jad.2014.04.064. Epub 2014 May 5.

PMID:
25012426
[PubMed - in process]
3.

The impact of mood episodes and duration of illness on cognition in bipolar disorder.

Buoli M, Caldiroli A, Caletti E, Zugno E, Altamura AC.

Compr Psychiatry. 2014 Jun 7. pii: S0010-440X(14)00147-3. doi: 10.1016/j.comppsych.2014.06.001. [Epub ahead of print]

PMID:
25011691
[PubMed - as supplied by publisher]
4.

Pattern of Pharmacotherapy by Episode Types for Patients With Bipolar Disorders and Its Concordance With Treatment Guidelines.

Baek JH, Ha K, Yatham LN, Chang JS, Ha TH, Jeon HJ, Hong KS, Chang SM, Ahn YM, Cho HS, Moon E, Cha B, Choi JE, Joo YH, Joo EJ, Lee SY, Park Y.

J Clin Psychopharmacol. 2014 Jul 8. [Epub ahead of print]

PMID:
25006813
[PubMed - as supplied by publisher]
5.

Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: Results from the bipolar CHOICE trial" [J. Affect. Disord. 161 (2014) 30-35].

Bobo WV, Reilly-Harrington NA, Ketter TA, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, McInnis MG, Friedman ES, Singh V, Tohen M, Bowden CL, Deckersbach T, Calabrese JR, Thase ME, Nierenberg AA, Rabideau DJ, Schoenfeld DA, Faraone SV, Kamali M.

J Affect Disord. 2014 Jul 3;167C:259-260. doi: 10.1016/j.jad.2014.06.025. [Epub ahead of print] No abstract available.

PMID:
24998842
[PubMed - as supplied by publisher]
6.

A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.

Sherwood Brown E, Davila D, Nakamura A, Carmody TJ, John Rush A, Lo A, Holmes T, Adinoff B, Caetano R, Swann AC, Sunderajan P, Bret ME.

Alcohol Clin Exp Res. 2014 Jul;38(7):2113-8. doi: 10.1111/acer.12445. Epub 2014 Jun 27.

PMID:
24976394
[PubMed - in process]
7.

Role of behavioral addictions in predicting reactivity in bipolar mood disorder patients.

Abolghasemi A, Sadeghi H, Kiamarsi A, Abbasi M.

Int J High Risk Behav Addict. 2014 Mar 10;3(1):e13909. doi: 10.5812/ijhrba.13909. eCollection 2014 Mar.

PMID:
24971298
[PubMed]
Free PMC Article
8.

Mixed depression: clinical features and predictors of its onset associated with antidepressant use.

Sani G, Napoletano F, Vöhringer PA, Sullivan M, Simonetti A, Koukopoulos A, Danese E, Girardi P, Ghaemi N.

Psychother Psychosom. 2014;83(4):213-21. doi: 10.1159/000358808. Epub 2014 Jun 19.

PMID:
24970376
[PubMed - in process]
9.

Differences between patients with borderline personality disorder who do and do not have a family history of bipolar disorder.

Zimmerman M, Martinez J, Young D, Chelminski I, Dalrymple K.

Compr Psychiatry. 2014 May 27. pii: S0010-440X(14)00130-8. doi: 10.1016/j.comppsych.2014.05.012. [Epub ahead of print]

PMID:
24962449
[PubMed - as supplied by publisher]
10.

Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial.

Findling RL, Pathak S, Earley WR, Liu S, DelBello MP.

J Child Adolesc Psychopharmacol. 2014 Jun 23. [Epub ahead of print]

PMID:
24956042
[PubMed - as supplied by publisher]
11.

Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders.

Hung CI, Liu CY, Hsiao MC, Yu NW, Chu CL.

BMC Psychiatry. 2014 Jun 21;14:185. doi: 10.1186/1471-244X-14-185.

PMID:
24952586
[PubMed - in process]
Free PMC Article
12.

[The validity and reliability of the brief-hypomanic attitudes and positive predictions inventory-Turkish version].

Maçkalı Z, Tosun A, Cağın Tosun O, Gürsu Hariri A, Akkaya C, Iyidoğan E, Süer Yalçın E.

Turk Psikiyatri Derg. 2014 Summer;25(2):124-32. Turkish.

PMID:
24936759
[PubMed - in process]
Free Article
13.

Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study.

Maripuu M, Wikgren M, Karling P, Adolfsson R, Norrback KF.

PLoS One. 2014 Jun 16;9(6):e98682. doi: 10.1371/journal.pone.0098682. eCollection 2014.

PMID:
24932586
[PubMed - in process]
Free PMC Article
14.

The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.

Riemann G, Weisscher N, Goossens PJ, Draijer N, Apenhorst-Hol M, Kupka RW.

BMC Psychiatry. 2014 Jun 9;14:172. doi: 10.1186/1471-244X-14-172.

PMID:
24912456
[PubMed - in process]
Free PMC Article
15.

A five-year follow-up study of neurocognitive functioning in bipolar disorder.

Santos JL, Aparicio A, Bagney A, Sánchez-Morla EM, Rodríguez-Jiménez R, Mateo J, Jiménez-Arriero MA.

Bipolar Disord. 2014 Jun 9. doi: 10.1111/bdi.12215. [Epub ahead of print]

PMID:
24909395
[PubMed - as supplied by publisher]
16.

Links between sleep and body mass index in bipolar disorders: An exploratory study.

Boudebesse C, Geoffroy PA, Henry C, Germain A, Scott J, Lajnef M, Leboyer M, Bellivier F, Etain B.

Eur Psychiatry. 2014 Jun 4. pii: S0924-9338(14)00089-3. doi: 10.1016/j.eurpsy.2014.04.006. [Epub ahead of print]

PMID:
24908150
[PubMed - as supplied by publisher]
17.

Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms.

Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez A, Vieta E, Martinez-Aran A, Torrent C; the CIBERSAM Functional Remediation Group.

Eur Neuropsychopharmacol. 2014 May 20. pii: S0924-977X(14)00148-5. doi: 10.1016/j.euroneuro.2014.05.010. [Epub ahead of print]

PMID:
24906790
[PubMed - as supplied by publisher]
18.

Mental disorders that exacerbated due to the Fukushima disaster, a complex radioactive contamination disaster.

Matsumoto J, Kunii Y, Wada A, Mashiko H, Yabe H, Niwa S.

Psychiatry Clin Neurosci. 2014 Mar;68(3):182-7.

PMID:
24895734
[PubMed - in process]
19.

Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial.

Salazar-Ospina A, Amariles P, Benjumea DM, Gutierrez F, Faus MJ, Rodriguez LF.

Trials. 2014 May 20;15:174. doi: 10.1186/1745-6215-15-174.

PMID:
24885673
[PubMed - in process]
Free PMC Article
20.

Nerve growth factor variations in patients with mood disorders: no changes in eight weeks of clinical treatment.

Liu X, Zhang T, He S, Hong B, Peng D, Su H, Li F, Tang Y, Lin Z, Fang Y, Jiang K.

Neuropsychiatr Dis Treat. 2014 May 15;10:835-40. doi: 10.2147/NDT.S62741. eCollection 2014.

PMID:
24868159
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk